{"SPADE_UN_17496": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_17496", "Peptide Name": "R-DIM-P-LF11-215", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "FWRIRIRRPRRIRIRWF", "Sequence Length": 17, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C117H187N43O18", "Mass": 2484.01, "PI": 12.0, "Net Charge": 8, "Hydrophobicity": -0.93, "Half Life": "Mammalian:1.1 hourYeast:3 minE.coli:2 min", "Literature": [{"Title": "Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies", "Pubmed ID": "32151609", "Reference": "Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8)183264.", "Author": "Grissenberger S, Riedl S, Rinner B, Leber R, Zweytick D.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=32151609"}], "Frequent Amino Acids": "RIF", "Absent Amino Acids": "ACDEGHKLMNOQSTUVY", "Basic Residues": 8, "Acidic Residues": 0, "Hydrophobic Residues": 9, "Polar Residues": 8, "Positive Residues": 8, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_06388", "Similarity": 1.0, "Sequence": "PFWRIRIRRPRRIRIRWFP"}, {"SPADE_ID": "SPADE_UN_00507", "Similarity": 1.0, "Sequence": "PFWRIRIRR"}, {"SPADE_ID": "SPADE_UN_04207", "Similarity": 1.0, "Sequence": "PFFWRIRIRR"}]}}}